Sequenom Posts 62 Percent Jump in Q2 Revenues, Inks Licensing Deal with Mayo Clinic | GenomeWeb

NEW YORK (GenomeWeb) – Sequenom reported after the close of the market on Tuesday that its diagnostic revenues in the second quarter increased 62 percent year over year.

For the three months ended June 30, the San Diego-based company pulled in $39.8 million, all from its Sequenom Center for Molecular Medicine business, compared to diagnostic revenues of $24.5 million in Q2 2013.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: transcriptome patterns of Zika-infected cells, updated Comparative Toxicogenomics Database, and more.

BMJ study says that about half of former hematology-oncology regulators now work for industry.

Science should wish PhDs who leave academia well, a Nature editorial says.

New York-based doctors announce the birth of a baby boy whose parents underwent mitochondrial transfer therapy, New Scientist reports.